Related Experiment Video
Updated: Jun 7, 2026

Monitoring Blood-Brain Barrier Opening in Rats with a Preclinical Focused Ultrasound System
Published on: September 13, 2024
Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities
Paul A Armitage1, Andrew J Farrall, Trevor K Carpenter
1Clinical Neurosciences, School of Molecular and Clinical Medicine, Western General Hospital, University of Edinburgh, Edinburgh, EH4 2XU, Scotland, UK. paul.armitage@ed.ac.uk
Abstract:
There is growing interest in investigating the role of subtle changes in blood-brain barrier (BBB) function in common neurological disorders and the possible use of imaging techniques to assess these abnormalities. Some studies have used dynamic contrast-enhanced MR imaging (DCE-MRI) and these have demonstrated much smaller signal changes than obtained from more traditional applications of the technique, such as in intracranial tumors and multiple sclerosis. In this work, preliminary results are presented from a DCE-MRI study of patients with mild stroke classified according to the extent of visible underlying white matter abnormalities. These data are used to estimate typical signal enhancement profiles in different tissue types and by degrees of white matter abnormality. The effect of scanner noise, drift and different intrinsic tissue properties on signal enhancement data is also investigated and the likely implications for interpreting the enhancement profiles are discussed. No significant differences in average signal enhancement or contrast agent concentration were observed between patients with different degrees of white matter abnormality, although there was a trend towards greater signal enhancement with more abnormal white matter. Furthermore, the results suggest that many of the factors considered introduce uncertainty of a similar magnitude to expected effect sizes, making it unclear whether differences in signal enhancement are truly reflective of an underlying BBB abnormality or due to an unrelated effect. As the ultimate aim is to achieve a reliable quantification of BBB function in subtle disorders, this study highlights the factors which may influence signal enhancement and suggests that further work is required to address the challenging problems of quantifying contrast agent concentration in healthy and diseased living human tissue and of establishing a suitable model to enable quantification of relevant physiological parameters. Meanwhile, it is essential that future studies use an appropriate control group to minimize these influences.
Insights
Dynamic contrast-enhanced MRI (DCE-MRI) shows subtle blood-brain barrier (BBB) changes in mild stroke. Preliminary results indicate that scanner noise and tissue properties introduce uncertainty, complicating BBB abnormality assessment.
Area of Science:
- Neurology
- Medical Imaging
- Biophysics
Background:
- Subtle blood-brain barrier (BBB) dysfunction is implicated in neurological disorders.
- Dynamic contrast-enhanced MRI (DCE-MRI) is explored for assessing BBB abnormalities.
- Previous DCE-MRI studies showed smaller signal changes in subtle BBB changes compared to tumors or MS.
Purpose of the Study:
- To present preliminary DCE-MRI results in mild stroke patients.
- To estimate signal enhancement profiles in different tissues and white matter abnormalities.
- To investigate factors affecting signal enhancement and their implications for BBB assessment.
Main Methods:
- DCE-MRI was used in mild stroke patients categorized by white matter abnormalities.
- Signal enhancement profiles were analyzed across tissue types and abnormality degrees.
- The influence of scanner noise, drift, and tissue properties on signal enhancement was investigated.
Main Results:
- No significant differences in average signal enhancement or contrast agent concentration were found between patient groups.
- A trend towards greater signal enhancement was observed with increased white matter abnormality.
- Factors like scanner noise and tissue properties introduce uncertainty comparable to expected effect sizes.
Conclusions:
- Current DCE-MRI findings in mild stroke are confounded by technical factors, making BBB abnormality assessment challenging.
- Further research is needed for reliable quantification of BBB function and contrast agent concentration in human tissues.
- Future studies must incorporate appropriate control groups to mitigate confounding influences on DCE-MRI signal enhancement.
More Related Videos
05:19Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury
Published on: October 18, 2024
07:22Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
Related Concept Videos
Magnetic Resonance Imaging
The Blood-brain Barrier